This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 24 print issues and online access
$259.00 per year
only $10.79 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Smith, I., Talbot, D. Cisplatin and its analogues in the treatment of advanced breast cancer: a review. Br J Cancer 65, 787–793 (1992). https://doi.org/10.1038/bjc.1992.169
Issue Date:
DOI: https://doi.org/10.1038/bjc.1992.169
This article is cited by
-
Effect of Smilax spp. and Phellinus linteus combination on cytotoxicity and cell proliferation of breast cancer cells
BMC Complementary Medicine and Therapies (2023)
-
Renal Medulla is More Sensitive to Cisplatin than Cortex Revealed by Untargeted Mass Spectrometry-Based Metabolomics in Rats
Scientific Reports (2017)
-
The Role of Platinum Compounds for the Treatment of Breast Cancer
Current Breast Cancer Reports (2013)
-
Predicting idiopathic toxicity of cisplatin by a pharmacometabonomic approach
Kidney International (2011)
-
Mitomycin C, vinblastine and cisplatin (MVP): an active and well-tolerated salvage regimen for advanced breast cancer
British Journal of Cancer (2005)